Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1990 Apr;34(4):610–613. doi: 10.1128/aac.34.4.610

Efficacy and safety of mercuric oxide in the treatment of bacterial blepharitis.

R A Hyndiuk 1, E M Burd 1, A Hartz 1
PMCID: PMC171652  PMID: 2344168

Abstract

A double-masked, placebo-controlled, randomized study was done to assess the safety and clinical and quantitative microbiologic efficacy of 1% mercuric oxide (yellow) ophthalmic ointment in the treatment of eyelid infections, i.e., bacterial blepharitis. A total of 39 patients with bacterial counts and clinical signs indicative of eyelid infection were treated twice daily for 7 days. Clinical biomicroscopic examination and quantitative microbiologic cultures were done just prior to initiation of treatment and again on days 3 and 7. Statistical analysis revealed a significant improvement in the clinical signs, bacterial count, cure rate, and improvement rate for subjects taking the active medication, compared with those taking the placebo on days 3 and 7. In addition, the medication was well tolerated.

Full text

PDF
610

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dougherty J. M., McCulley J. P. Bacterial lipases and chronic blepharitis. Invest Ophthalmol Vis Sci. 1986 Apr;27(4):486–491. [PubMed] [Google Scholar]
  2. Dougherty J. M., McCulley J. P. Comparative bacteriology of chronic blepharitis. Br J Ophthalmol. 1984 Aug;68(8):524–528. doi: 10.1136/bjo.68.8.524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Kastl P. R., Ali Z., Mather F. Placebo-controlled, double-blind evaluation of the efficacy and safety of yellow mercuric oxide in suppression of eyelid infections. Ann Ophthalmol. 1987 Oct;19(10):376–379. [PubMed] [Google Scholar]
  4. Khan J. A., Hoover D., Ide C. H. Methicillin-resistant Staphylococcus epidermidis blepharitis. Am J Ophthalmol. 1984 Nov;98(5):562–565. doi: 10.1016/0002-9394(84)90241-1. [DOI] [PubMed] [Google Scholar]
  5. McCulley J. P., Dougherty J. M. Blepharitis associated with acne rosacea and seborrheic dermatitis. Int Ophthalmol Clin. 1985 Spring;25(1):159–172. doi: 10.1097/00004397-198502510-00010. [DOI] [PubMed] [Google Scholar]
  6. McCulley J. P., Dougherty J. M., Deneau D. G. Classification of chronic blepharitis. Ophthalmology. 1982 Oct;89(10):1173–1180. doi: 10.1016/s0161-6420(82)34669-2. [DOI] [PubMed] [Google Scholar]
  7. Smolin G., Okumoto M. Staphylococcal blepharitis. Arch Ophthalmol. 1977 May;95(5):812–816. doi: 10.1001/archopht.1977.04450050090009. [DOI] [PubMed] [Google Scholar]
  8. Valenton M. J., Okumoto M. Toxin-producing strains of Staphylococcus epidermidis (albus). Isolates from patients with staphylococcic blepharoconjunctivitis. Arch Ophthalmol. 1973 Mar;89(3):186–189. doi: 10.1001/archopht.1973.01000040188004. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES